Inhibikase Therapeutics to Present at H.C. Wainwright & Co. Global Life Sciences Virtual Conference
ATLANTA, Mar. 2, 2021 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (NASDAQ: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the...